Replies to post #197267 on Innovation Pharmaceuticals Inc (IPIX)

[FlashingLeather]

agree there frrol...appreciate your thoughts

[MinnieM]

I went back and listened to the audio while following the slide deck for the most recent presentation on the company website. All comments relate to trial completion without any mention of a prurisol interim analysis.

Events and Presentations
http://www.ipharminc.com/new-events-and-presentations/

I've jotted down the times in the presentation when completion or read out was mentioned regarding prurisol.

2:25
3:47
13:33
20:31

Audio: http://www.ipharminc.com/s/IPIX-Company-Presentation-AUDIO-BioCentury-NewsMakers-8Sep20171.mp3

Slide deck: http://www.ipharminc.com/s/IPIX-Company-Presentation-BioCentury-NewsMakers-Conference-8Sep2017-tddb.pdf

Remaining Anticipated Clinical Milestones 2017


This presentation on September 8, 2017 may have been our notification. The move from interim in 2nd quarter to 3rd quarter was also found in a slide deck.

The email cabel posted on September 14, 2017 is what makes this different. It created angst even though the information had already been out for six days.






In Reply to 'frrol'
That wasn't a shareholder message of course, that was a response to an e-mail inquiry. If true (I believe it is), that was not appropriate.